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A balance of positive and negative signals that are trans-
mitted by different surface receptors controls the effector
functions of NK cells. To date our understanding about
the integration of positive and negative signals and the
decision-making process inside NK cells remains poor.
With the help of bioinformatic modelling we try to under-
stand how NK cells first integrate antagonising signals and
then compute a reliable killing decision. Gradual signal
input through activating and inhibitory receptors is inte-
grated to come to a "yes or no" decision by the NK cell to
kill an attached target cell. Triggering of activating recep-
tors leads to Src kinase activation and Vav-1 phosphoryla-
tion, whereas inhibitory receptors dephosphorylate Vav-1
via the phosphatase SHP-1. Therefore, we proposed in a
first hypothesis, that Vav-1 is the decision making point in
the signal transduction network. With this hypothesis we
created a family of simplified models describing NK cell
activation upon various stimuli. The predictions derived
from these models were compared with experimental
data. Our experiments showed that increased clustering of
activating receptors lead to a rapid switch-like increase in
Vav-1 phosphorylation. Similarly, titrating the engage-
ment of inhibitory receptors resulted in switch-like
dephosphorylation of Vav-1. Testing NK cell activity after
various amounts of activating and inhibitory receptor
engagement revealed a functional dominance of inhibi-
tory receptors. Our current model is consistent with a cen-
tral role of Vav-1 in the decision making process of NK
cells and enables a novel insight into the integration of
positive and negative signals during lymphocyte activa-
tion.
from 12th Joint Meeting of the Signal Transduction Society (STS). Signal Transduction: Receptors, Mediators and Genes
Weimar, Germany. 29–31 October 2008
Published: 26 February 2009
Cell Communication and Signaling 2009, 7(Suppl 1):A90 doi:10.1186/1478-811X-7-S1-A90
<supplement> <title> <p>12th Joint Meeting of the Signal Transduction Society (STS). Signal Transduction: Receptors, Mediators and Genes</p> </title> <editor>Frank Entschladen, Karlheinz Friedrich, Ralf Hass and Ottmar Janssen</editor> <note>Meeting abstracts – A single PDF containing all abstracts in this Supplement is available <a href="http://www.biomedcentral.com/content/files/pdf/1478-811X-7-S1-full.pdf">here</a>.</note> </supplement>
This abstract is available from: http://www.biosignaling.com/content/7/S1/A90
© 2009 Urlaub et al; licensee BioMed Central Ltd. 
